Tabula Rasa HealthCare (NASDAQ:TRHC – Get Rating) had its price target boosted by equities researchers at Piper Sandler from $4.00 to $6.00 in a report released on Friday, The Fly reports. Piper Sandler's price objective indicates a potential upside of 2.21% from the stock's previous close.
Tabula Rasa HealthCare Price Performance
NASDAQ TRHC opened at $5.87 on Friday. The firm has a market cap of $159.19 million, a P/E ratio of -0.96 and a beta of 1.54. The stock's 50-day moving average is $5.79 and its 200-day moving average is $4.82. Tabula Rasa HealthCare has a one year low of $2.09 and a one year high of $6.69.
Get Tabula Rasa HealthCare alerts:Insider Activity at Tabula Rasa HealthCare
In other news, CFO Thomas Cancro bought 11,500 shares of the company's stock in a transaction that occurred on Monday, December 12th. The shares were acquired at an average price of $4.34 per share, with a total value of $49,910.00. Following the transaction, the chief financial officer now owns 211,500 shares in the company, valued at $917,910. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 7.25% of the stock is owned by insiders.
Institutional Investors Weigh In On Tabula Rasa HealthCare
Hedge funds and other institutional investors have recently bought and sold shares of the company. Eagle Asset Management Inc. increased its position in shares of Tabula Rasa HealthCare by 27.8% during the 2nd quarter. Eagle Asset Management Inc. now owns 20,402 shares of the company's stock worth $52,000 after purchasing an additional 4,434 shares during the last quarter. Teramo Advisors LLC increased its position in shares of Tabula Rasa HealthCare by 66.7% during the 2nd quarter. Teramo Advisors LLC now owns 25,000 shares of the company's stock worth $64,000 after purchasing an additional 10,000 shares during the last quarter. Mattern Capital Management LLC increased its position in shares of Tabula Rasa HealthCare by 27.9% during the 3rd quarter. Mattern Capital Management LLC now owns 36,323 shares of the company's stock worth $174,000 after purchasing an additional 7,920 shares during the last quarter. SG Americas Securities LLC acquired a new position in shares of Tabula Rasa HealthCare during the 2nd quarter worth approximately $44,000. Finally, Teachers Retirement System of The State of Kentucky acquired a new position in shares of Tabula Rasa HealthCare during the 3rd quarter worth approximately $25,000. Institutional investors and hedge funds own 60.90% of the company's stock.
About Tabula Rasa HealthCare
(Get Rating)
Tabula Rasa Healthcare, Inc is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services.
See Also
- Get a free copy of the StockNews.com research report on Tabula Rasa HealthCare (TRHC)
- FuelCell Energy Gains Traction, Shares Surge
- Solo Brands May Remind Investors Why Cash is King
- Someone Is Buying The Dip In MongoDB
- Cameco: Is the New Uranium Bull Market Here to Stay?
- Etsy Stock: Crafty Bargain or Piece of Junk?
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.